what class of drug is tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain tirzepatide med class drug NHS

In turn, endothelial cell dysfunction affects the synthesis and secretion of the glycocalyx, thereby forming a vicious circle (58)

Tirzepatide is a once weekly injectable medication that works as a dual GIP (Glucose dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon Like Peptide-1) receptor agonist

Semaglutide is a GLP-1 medication, while Tirzepatide works on GLP-1 and GIP pathways

The SYNCHRONIZE-MASLD phase 3, randomized, double-blind, placebo-controlled trial included 216 adults (131 female and 85 male) with obesity (defined as a body mass index 30 kg m 2 or 27 kg m 2 with at least one obesity complication) and at-risk metabolic dysfunction-associated steatotic liver disease (MASLD), defined by MASLD with evidence of liver inflammation and/or fibrosis by noninvasive tests (NITs) or biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH)

And I think that's great insight

The long-term effects of using tirzepatide require ongoing monitoring, and its essential to discuss potential risks with your healthcare provider